Telehealth & Digital Health

Crinetics Pharmaceuticals aims to disrupt Brazil's acromegaly treatment with Palsonify, a once-daily pill challenging the standard of monthly injections.

With critical data due in 2026 and a leaner financial strategy, Zentalis is advancing its targeted therapy for a hard-to-treat ovarian cancer.

A groundbreaking study of 78,000 people shows most with acne and psoriasis manage their conditions alone, outside the clinic. Here's what it means.

A new national initiative aims to connect siloed dental records to the broader healthcare system, promising to improve patient safety and reduce costly care gaps.

A new lithium formula boosts brain delivery in a key trial, offering hope for safer, more effective treatments for Alzheimer's, bipolar disorder, and more.

A new RNA drug shows promise by reducing harmful belly fat while preserving muscle, but modest overall weight loss in early trials spooks investors.

A new high-tech wellness center arrives in Boulder, offering cutting-edge services. But does the science support the high price of proactive health?

Facing a cancer diagnosis is overwhelming. Manulife's new Cancer Coach program offers a lifeline with personalized support for daily life and work.

American Specialty Health's entire coaching team is now NBHWC-certified, a move setting a new quality benchmark in the booming digital health market.

Experic and Flurry Powders form a strategic alliance to accelerate complex therapies by combining advanced particle engineering with GMP manufacturing.

GuideWell's 2025 Impact Report details a multi-pronged strategy using AI, community investment, and value-based care to tackle healthcare costs.

Cipla Health launches a Masala Guava flavored ORS, targeting India's daily wellness market by turning a medical staple into an enjoyable hydration choice.

A new Phase 2 trial is testing an inhaled version of a key IPF drug, aiming to reduce severe side effects and transform treatment for the fatal lung disease.

New research reveals a startling link between common liver conditions and heart failure in older adults with atrial fibrillation, urging a new look at risk.

Telehealth platforms like ReflexMD offer cheaper, compounded GLP-1s for weight loss. But what are the risks, and what do consumers need to know?

With a history of billion-dollar deals, Mark Altmeyer takes the helm at ReproNovo, aiming to commercialize its promising fertility and women's health pipeline.

The University of Miami launches a new program to arm doctors with business skills, addressing a critical leadership gap in the evolving healthcare industry.

A new oral drug is being tested with existing therapies, offering a two-pronged attack on the glycogen buildup that defines this debilitating rare disease.

A novel blood test from C2N Diagnostics, used in a major Alzheimer's trial, shows promise in predicting disease progression, heralding a new era of precision medicine.

With a new CFO who helped steer a multi-billion dollar acquisition, Bambusa Therapeutics signals major growth plans for its innovative antibody platform.